A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Clinical trial NCT07502443 · RECRUITING
Trial details
- NCT number
- NCT07502443
- Sponsor
- Alkermes, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2027-05-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.